New York

FDA: Two more eye drop brands recalled for risk

FDA recalls two more eye drop brands for risk

FDA recalls two more eye drop brands for risk


US health officials have warned consumers of two more eye drop recalls due to the risk of contamination that could lead to vision problems and serious injury.

The announcement follows a recall of eye drops linked to an outbreak of drug-resistant infections in India last month. One person died and at least five of her suffered permanent blindness.

There is no indication that the latest recall is related to these products.

The Food and Drug Administration has posted separate recall notices for certain eye drops distributed in the United States. Pharmadica and Apotex After the companies announced they were voluntarily withdrawing some lots of their products from the market, the companies said the recall was implemented in consultation with the FDA.

On Friday, Pharmadica announced it was recalling two lots of Purely Soothing 15% MSM Drops due to a “potentially blinding” issue. Over-the-counter drops are designed to treat eye irritation. The Phoenix-based company said consumers should stop using the drops immediately and return them to where they were purchased.

The recall affects about 2,900 bottles, according to the company. Drops are manufactured in Arizona.

Last week, the FDA posted another recall announcement from Apotex recalling six lots of prescription eye drops used to treat glaucoma. The company said it initiated the recall after cracks were found in a handful of bottle caps.

Drops are distributed as brimonidine tartrate eye drops. At 0.15%, from April last year he was sold through February.

Apotex said in an email that the drops were manufactured in Canada.The company has not received any reports of fall-related injuries.


The Associated Press’ Health Sciences Division is supported by the Scientific and Educational Media Group at the Howard Hughes Medical Institute. AP is solely responsible for all content. FDA: Two more eye drop brands recalled for risk

Back to top button